Skip to main content

Remote Job Finders (RJF)

$100,000 H-1B Fee Leaves Biopharma Grappling With Impact

The Trump administration’s recently announced fee for new H-1B visa petitions is “completely unreasonable,” an immigration attorney told BioSpace. Attorneys and talent acquisition experts discuss how the fee could impact biopharma and confusion around the proclamation.

Talent Acquisition Leaders Reframe Recruiting, Focus On Internal Mobility

Talent acquisition leaders at leading pharma and biotech organizations are leveraging technologies, including automation, to develop internal talent marketplaces and systems that support upskilling and reskilling their workforce. BioSpace spoke to leaders at Pfizer and Bayer about their evolving approach to resourcing.
Scroll to top